Acadia Pharmaceuticals (ACAD) Shares Outstanding: 2009-2024
- Acadia Pharmaceuticals' Shares Outstanding rose 1.25% to $166.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $166.7 million, marking a year-over-year increase of 1.25%. This contributed to the annual value of $166.7 million for FY2024, which is 1.25% up from last year.
- According to the latest figures from Q4 2024, Acadia Pharmaceuticals' Shares Outstanding is $166.7 million, which was up 1.25% from $164.7 million recorded in Q4 2023.
- Acadia Pharmaceuticals' Shares Outstanding's 5-year high stood at $166.7 million during Q4 2024, with a 5-year trough of $159.6 million in Q4 2020.
- Moreover, its 3-year median value for Shares Outstanding was $164.7 million (2023), whereas its average is $164.5 million.
- Data for Acadia Pharmaceuticals' Shares Outstanding shows a peak YoY climbed of 2.81% (in 2020) over the last 5 years.
- Over the past 5 years, Acadia Pharmaceuticals' Shares Outstanding (Quarterly) stood at $159.6 million in 2020, then increased by 0.86% to $161.0 million in 2021, then increased by 0.65% to $162.1 million in 2022, then climbed by 1.60% to $164.7 million in 2023, then rose by 1.25% to $166.7 million in 2024.
- Its last three reported values are $166.7 million in Q4 2024, $164.7 million for Q4 2023, and $162.1 million during Q4 2022.
